Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

[Leptin induced apoptosis in rat adipose-derived stem cells cultured in vitro].

Jiang Y., Qiao H., Liu M., Li Q., Sun Y., Zhang J.

Animal Study on Face & Skin, published in Sheng Wu Gong Cheng Xue Bao (2008) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Sheng Wu Gong Cheng Xue Bao (2008)
Country
China
Reported sample size
—
Source database
PubMed
PMID
18837398
Citations
1

Abstract (original English)

To determine the direct effect of leptin on adipose tissue apoptosis in vitro using rat adipose-derived stem cells (ADSCs), we isolated the ADSCs of rat epididymis adipose tissue by collagenase digestion, filtration, and subsequent centrifugation. Cell cultures with or without leptin (10(-9) mol/L, 10(-8) mol/L, 10(-7) mol/L and 10(-6) mol/L) were incubated for different time. We examined the cell surface phenotype by immunofluorescence and detected the apoptosis morphological changes of ADSCs by laser scanning confocal microscope (LCSM). The number of apoptotic cells was determined by flow cytometry assay after annexin V binding and PI staining. Caspase-3 activity was measured by spectrofluorometry. The present study demonstrates that leptin treatment causes a marked increase in adipose-derived stem cell apoptosis. With the LCSM, after being treated with leptin, ADSCs showed the typical characteristic of apoptosis. Leptin in used concentrations (0 mol/L, 10(-8) mol/L, 10(-7) mol/L, 10(-6) mol/L) caused a marked increase in cell apoptosis after 48 h incubation time (for 2.50% +/- 0.72%, 6.78% +/- 1.99%, 11.99% +/- 1.58% and 17.93% +/- 4.82%, respectively, P < 0.05). Caspase-3 activity increased and reached a maximal level after 48 h in a linear fashion. The effect of leptin was dose-dependent and time-dependent. Leptin has been demonstrated to induce preadipocyte and adipocyte

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAnimalsApoptosisCaspase 3Cells, CulturedEpididymisLeptinMaleMesenchymal Stem CellsRats

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research